Growth Disorder
📧 Sign up to get email alerts when something new happens for Growth Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation [Phase 2]
Phase 2 trial evaluating sirolimus for segmental overgrowth due to somatic PI3K activation (PROS) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature [Phase 2]
Phase 2 trial evaluating a luteinizing hormone-releasing hormone analog in pubertal patients with extreme short stature has completed.